hydroxypropyl tetrahydropyrantriol

Small moleculeexperimental

Tetrahydropyran (THP) is the organic compound consisting of a saturated six-membered ring containing five carbon atoms and one oxygen atom. It is named by reference to pyran, which contains two double bonds, and may be produced from it by adding four hydrogens. In 2013, its preferred IUPAC name was established as oxane. The compound is a colourless volatile liquid. Derivatives of tetrahydropyran are, however, more common. 2-Tetrahydropyranyl (THP-) ethers derived from the reaction of alcohols and 3,4-dihydropyran are commonly used as protecting groups in organic synthesis. Furthermore, a tetrahydropyran ring system, i.e., five carbon atoms and an oxygen, is the core of pyranose sugars, such as glucose. — Wikipedia

Clinical trial activity

2 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0

Earliest trial started Aug 1, 2006 (NCT00403702)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • hydroxypropyltetrahydropyrantriol
  • hydroxypropyl tetrahydropyrantriol
  • oxane
  • oxane

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00818545N/ANov 1, 2007L'Oreal, Paris Diderot University
NCT00403702Phase 2/Phase 3 (Phase 3)Aug 1, 2006Asociación para Evitar la Ceguera en México
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Asociación para Evitar la Ceguera en MéxicoAcademic/Hospital1112006
L'OrealFor profit1112007
Paris Diderot UniversityAcademic/Hospital1012007
3 organizations
Page 1 / 1